SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001144204-14-044070
Filing Date
2014-07-22
Accepted
2014-07-22 09:48:00
Documents
3
Period of Report
2014-08-14
Effectiveness Date
2014-07-22

Document Format Files

Seq Description Document Type Size
1 DEF 14A v384044_def14a.htm DEF 14A 640943
2 GRAPHIC tproxypg1.jpg GRAPHIC 287748
3 GRAPHIC tproxypg2.jpg GRAPHIC 163747
  Complete submission text file 0001144204-14-044070.txt   1264676
Mailing Address 605 THIRD AVENUE 34TH FLOOR NEW YORK NY 10158
Business Address 605 THIRD AVENUE 34TH FLOOR NEW YORK NY 10158 646-666-3188
BRAINSTORM CELL THERAPEUTICS INC. (Filer) CIK: 0001137883 (see all company filings)

IRS No.: 208133057 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-54365 | Film No.: 14985817
SIC: 2836 Biological Products, (No Diagnostic Substances)